Dana (NYSE:DAN) Downgraded by Zacks Research to Hold
Zacks Research downgraded shares of Dana (NYSE:DAN – Free Report) from a strong-buy rating to a hold rating in a report released on Wednesday morning,Zacks.com reports. Other analysts also recently issued research reports about the company. Cfra Research upgraded Dana from a “moderate sell” rating to a “hold” rating in a research note on Tuesday, […]
StandardAero (NYSE:SARO) Upgraded to Hold at Zacks Research
Zacks Research upgraded shares of StandardAero (NYSE:SARO – Free Report) from a strong sell rating to a hold rating in a research report released on Wednesday,Zacks.com reports. Several other research firms have also recently weighed in on SARO. Barclays started coverage on shares of StandardAero in a research note on Friday, September 12th. They set […]
NuScale Power (NYSE:SMR) Cut to Strong Sell at Zacks Research
NuScale Power (NYSE:SMR – Get Free Report) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday,Zacks.com reports. SMR has been the topic of several other research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of NuScale Power […]
Zacks Research Upgrades Mereo BioPharma Group (NASDAQ:MREO) to Hold
Mereo BioPharma Group (NASDAQ:MREO – Get Free Report) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Wednesday,Zacks.com reports. A number of other research firms have also weighed in on MREO. JPMorgan Chase & Co. upped their target price on shares […]
Travere Therapeutics (NASDAQ:TVTX) Rating Lowered to “Hold” at Zacks Research
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports. Several other research analysts also recently weighed in on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Travere […]
ACV Auctions (NYSE:ACVA) Downgraded to Hold Rating by Zacks Research
Zacks Research cut shares of ACV Auctions (NYSE:ACVA – Free Report) from a strong-buy rating to a hold rating in a research note published on Wednesday,Zacks.com reports. A number of other equities research analysts also recently commented on the company. Barclays upgraded ACV Auctions to a “hold” rating in a research report on Tuesday. Barrington […]
Cytosorbents (NASDAQ:CTSO) Receives Buy Rating from D. Boral Capital
Cytosorbents (NASDAQ:CTSO – Get Free Report)‘s stock had its “buy” rating restated by analysts at D. Boral Capital in a report released on Friday,Benzinga reports. They presently have a $10.00 price target on the medical research company’s stock. Several other research analysts have also recently commented on the company. Weiss Ratings reiterated a “sell (e+)” […]
D. Boral Capital Reiterates Buy Rating for Trevi Therapeutics (NASDAQ:TRVI)
Trevi Therapeutics (NASDAQ:TRVI – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a note issued to investors on Friday,Benzinga reports. They currently have a $19.00 target price on the stock. D. Boral Capital’s price target would suggest a potential upside of 67.11% from the company’s current […]
Motorcar Parts of America (NASDAQ:MPAA) Downgraded to “Strong Sell” Rating by Zacks Research
Zacks Research cut shares of Motorcar Parts of America (NASDAQ:MPAA – Free Report) from a hold rating to a strong sell rating in a research report sent to investors on Wednesday,Zacks.com reports. Separately, Weiss Ratings cut shares of Motorcar Parts of America from a “hold (c-)” rating to a “sell (d+)” rating in a research […]
last updated on 15 Nov 00:18